ReviewClinical and translational science2024

Clinical pharmacokinetics and pharmacodynamics of venetoclax, a selective B-cell lymphoma-2 inhibitor.

Ahmed Hamed Salem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.